{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:50:10Z","timestamp":1791352210879,"version":"4.3.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.bbalip.2011.10.007","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T17:09:37Z","timestamp":1318871377000},"page":"833-842","source":"Crossref","is-referenced-by-count":52,"title":["Allelic and phenotypic spectrum of plasma triglycerides"],"prefix":"10.1016","volume":"1821","author":[{"given":"Christopher T.","family":"Johansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2011.10.007_bb0255","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0002-9149(00)01127-9","article-title":"Evidence that triglycerides are an independent coronary heart disease risk factor","volume":"86","author":"Cullen","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0260","first-page":"89","article-title":"The independent relationship between triglycerides and coronary heart disease","volume":"5","author":"Morrison","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0265","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.atherosclerosis.2008.08.040","article-title":"Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: a systematic review of the epidemiological studies","volume":"203","author":"Labreuche","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0270","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","article-title":"Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies","volume":"3","author":"Hokanson","year":"1996","journal-title":"J. Cardiovasc. Risk"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0275","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0280","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0285","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/jama.2008.621","article-title":"Nonfasting triglycerides and risk of ischemic stroke in the general population","volume":"300","author":"Freiberg","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0290","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0295","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.2008.901","article-title":"How to use an article about genetic association. A: background concepts","volume":"301","author":"Attia","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0300","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.2008.946","article-title":"How to use an article about genetic association. B: are the results of the study valid?","volume":"301","author":"Attia","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0305","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jama.2008.993","article-title":"How to use an article about genetic association. C: what are the results and will they help me in caring for my patients?","volume":"301","author":"Attia","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0310","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0315","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1194\/jlr.R009720","article-title":"Genetic determinants of plasma triglycerides","volume":"52","author":"Johansen","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0320","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0325","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ng.628","article-title":"Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia","volume":"42","author":"Johansen","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20080595","article-title":"Glucokinase and molecular aspects of liver glycogen metabolism","volume":"414","author":"Agius","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0335","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.2337\/db08-0516","article-title":"Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations","volume":"57","author":"Orho-Melander","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0340","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1093\/hmg\/ddp357","article-title":"The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver","volume":"18","author":"Beer","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0345","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2337\/db07-1807","article-title":"The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population","volume":"57","author":"Vaxillaire","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0350","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ng.521","article-title":"Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge","volume":"42","author":"Saxena","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0355","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/ng.520","article-title":"New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk","volume":"42","author":"Dupuis","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0360","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00125-007-0865-z","article-title":"The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes","volume":"51","author":"Sparso","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0365","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2337\/dc10-2218","article-title":"Variants of GCKR affect both {beta}-cell and kidney function in patients with newly diagnosed type 2 diabetes: the Verona newly diagnosed type 2 diabetes study 2","volume":"34","author":"Bonetti","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0370","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/ATVBAHA.110.216333","article-title":"TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population","volume":"31","author":"Varbo","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0375","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1042\/BST0390684","article-title":"Tribbles: 'puzzling' regulators of cell signalling","volume":"39","author":"Kiss-Toth","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0380","doi-asserted-by":"crossref","first-page":"42703","DOI":"10.1074\/jbc.M407732200","article-title":"Human tribbles, a protein family controlling mitogen-activated protein kinase cascades","volume":"279","author":"Kiss-Toth","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0385","doi-asserted-by":"crossref","first-page":"18379","DOI":"10.1074\/jbc.M610792200","article-title":"Human tribbles-1 controls proliferation and chemotaxis of smooth muscle cells via MAPK signaling pathways","volume":"282","author":"Sung","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0390","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1084\/jem.20070183","article-title":"Enhanced TLR-mediated NF-IL6 dependent gene expression by Trib1 deficiency","volume":"204","author":"Yamamoto","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0395","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1172\/JCI44213","article-title":"Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice","volume":"120","author":"Burkhardt","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0400","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MOL.0b013e32834469b3","article-title":"Functional validation of new pathways in lipoprotein metabolism identified by human genetics","volume":"22","author":"Bauer","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0405","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrg2481","article-title":"Plasma lipoproteins: genetic influences and clinical implications","volume":"10","author":"Hegele","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0410","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1161\/ATVBAHA.111.224139","article-title":"Evidence of How rs7575840 Influences Apolipoprotein B-Containing Lipid Particles","volume":"31","author":"Haas","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0415","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.6857276","article-title":"Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse","volume":"221","author":"Paterniti","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0420","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2007.24","article-title":"Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia","volume":"39","author":"Peterfy","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0425","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MOL.0b013e32833854c0","article-title":"Lipase maturation factor 1: structure and role in lipase folding and assembly","volume":"21","author":"Doolittle","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0430","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1194\/jlr.M011155","article-title":"Lipase maturation factor 1 is required for endothelial lipase activity","volume":"52","author":"Ben-Zeev","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0435","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1194\/jlr.M900196-JLR200","article-title":"A quantitative assay measuring the function of lipase maturation factor 1","volume":"50","author":"Yin","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0440","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0009-3084(98)00039-5","article-title":"Combined lipase deficiency (cld\/cld) in mice affects differently post-translational processing of lipoprotein lipase, hepatic lipase and pancreatic lipase","volume":"93","author":"Scow","year":"1998","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0445","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1210\/jc.2009-0594","article-title":"Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia","volume":"94","author":"Cefalu","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0450","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1074\/jbc.M211932200","article-title":"Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1","volume":"278","author":"Ioka","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0455","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2007.02.002","article-title":"Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons","volume":"5","author":"Beigneux","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0460","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/ATVBAHA.110.214718","article-title":"Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells","volume":"31","author":"Gin","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0465","doi-asserted-by":"crossref","first-page":"30240","DOI":"10.1074\/jbc.M109.046391","article-title":"Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase","volume":"284","author":"Beigneux","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0470","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2217\/clp.10.43","article-title":"GPIHBP1 and the processing of triglyceride-rich lipoproteins","volume":"5","author":"Beigneux","year":"2010","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cmet.2010.04.016","article-title":"GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries","volume":"12","author":"Davies","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0010","doi-asserted-by":"crossref","first-page":"19735","DOI":"10.1074\/jbc.M111.242024","article-title":"Assessing the role of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1's three-finger domain in binding lipoprotein lipase","volume":"286","author":"Beigneux","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0015","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/nar\/29.10.2154","article-title":"CREB-H: a novel mammalian transcription factor belonging to the CREB\/ATF family and functioning via the box-B element with a liver-specific expression","volume":"29","author":"Omori","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0020","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/nar\/gki332","article-title":"The liver-enriched transcription factor CREB-H is a growth suppressor protein underexpressed in hepatocellular carcinoma","volume":"33","author":"Chin","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2005.11.040","article-title":"Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response","volume":"124","author":"Zhang","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0030","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/hep.22439","article-title":"Hepatocyte nuclear factor 4alpha is implicated in endoplasmic reticulum stress-induced acute phase response by regulating expression of cyclic adenosine monophosphate responsive element binding protein H","volume":"48","author":"Luebke-Wheeler","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0035","doi-asserted-by":"crossref","first-page":"e6796","DOI":"10.1371\/journal.pone.0006796","article-title":"Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human","volume":"4","author":"Rakhshandehroo","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0040","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.bbrc.2009.12.046","article-title":"The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha","volume":"391","author":"Danno","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cmet.2010.02.016","article-title":"Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH","volume":"11","author":"Lee","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0050","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nm.2347","article-title":"The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism","volume":"17","author":"Lee","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0055","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nrg2670","article-title":"Common disorders are quantitative traits","volume":"10","author":"Plomin","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11010-008-0005-1","article-title":"Hypertriglyceridemia: phenomics and genomics","volume":"326","author":"Hegele","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0065","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1093\/hmg\/ddp361","article-title":"A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia","volume":"18","author":"Hegele","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0070","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/hmg\/ddn188","article-title":"Polygenic determinants of severe hypertriglyceridemia","volume":"17","author":"Wang","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0075","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/ATVBAHA.111.226365","article-title":"An Increased Burden of Common and Rare Lipid-Associated Risk Alleles Contributes to the Phenotypic Spectrum of Hypertriglyceridemia","volume":"31","author":"Johansen","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0080","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1161\/ATVBAHA.107.150680","article-title":"Resequencing genomic DNA of patients with severe hypertriglyceridemia","volume":"27","author":"Wang","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0085","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/humu.1380040303","article-title":"Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels","volume":"4","author":"de Knijff","year":"1994","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0090","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2796.1992.tb01254.x","article-title":"The role of apolipoprotein E genetic variants in lipoprotein disorders","volume":"231","author":"Rall","year":"1992","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOL.0b013e3283471972","article-title":"Genetic bases of hypertriglyceridemic phenotypes","volume":"22","author":"Johansen","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0100","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0021-9258(18)94212-2","article-title":"Genetic and developmental regulation of the lipoprotein lipase gene: loci both distal and proximal to the lipoprotein lipase structural gene control enzyme expression","volume":"264","author":"Kirchgessner","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1139\/Y09-005","article-title":"Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review","volume":"87","author":"Rahalkar","year":"2009","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0110","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1100992108","article-title":"Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1","author":"Voss","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-291X(70)90468-7","article-title":"A specific apoprotein activator for lipoprotein lipase","volume":"41","author":"LaRosa","year":"1970","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0120","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1172\/JCI113246","article-title":"Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease","volume":"80","author":"Connelly","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/ATVBAHA.108.178756","article-title":"Triglyceride-rich lipoproteins and plasma lipid transport","volume":"30","author":"Havel","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1373\/clinchem.2004.044826","article-title":"Apolipoprotein A5 and hypertriglyceridemia","volume":"51","author":"Charlton-Menys","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0135","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.ATV.0000153087.36428.dd","article-title":"Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia","volume":"25","author":"Priore Oliva","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0140","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1172\/JCI24471","article-title":"Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment","volume":"115","author":"Marcais","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0145","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2796.2007.01912.x","article-title":"Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene","volume":"263","author":"Priore Oliva","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.mol.0000217892.00618.54","article-title":"APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency","volume":"17","author":"Calandra","year":"2006","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/CIRCGENETICS.109.908905","article-title":"Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects","volume":"3","author":"Franssen","year":"2010","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0160","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1194\/jlr.M002717","article-title":"Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia","volume":"51","author":"Olivecrona","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2796.2011.02361.x","article-title":"Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation","author":"Coca-Prieto","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0170","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/CIRCGENETICS.109.908905","article-title":"Chylomicronemia with Low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects","volume":"3","author":"Franssen","year":"2010","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0175","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/ATVBAHA.109.186577","article-title":"Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase","volume":"29","author":"Beigneux","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-511X-6-23","article-title":"Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650)","volume":"6","author":"Wang","year":"2007","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0185","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.bbalip.2007.10.005","article-title":"Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution","volume":"1771","author":"Gin","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00041433-200106000-00009","article-title":"Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism","volume":"12","author":"Shachter","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00041433-200406000-00002","article-title":"The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?","volume":"15","author":"van Dijk","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0200","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1126\/science.2167514","article-title":"Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice","volume":"249","author":"Ito","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0205","doi-asserted-by":"crossref","first-page":"23610","DOI":"10.1016\/S0021-9258(17)31559-4","article-title":"Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia","volume":"269","author":"Maeda","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0210","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1126\/science.1161524","article-title":"A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection","volume":"322","author":"Pollin","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2011.10.007_bb0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng814","article-title":"Angptl3 regulates lipid metabolism in mice","volume":"30","author":"Koishi","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0220","first-page":"70","article-title":"Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans","volume":"119","author":"Romeo","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0225","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ng1984","article-title":"Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL","volume":"39","author":"Romeo","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0230","first-page":"11","article-title":"Common and rare gene variants affecting plasma LDL cholesterol","volume":"29","author":"Burnett","year":"2008","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0235","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jmb.2008.09.006","article-title":"Reconstituting initial events during the assembly of apolipoprotein B-containing lipoproteins in a cell-free system","volume":"383","author":"Jiang","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0240","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","article-title":"Exome Sequencing, Mutations in ANGPTL3, and Familial Combined Hypolipidemia","volume":"363","author":"Musunuru","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0245","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/ncpcardio1250","article-title":"Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia","volume":"5","author":"Samaha","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.bbalip.2011.10.007_bb0250","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(10)60284-X","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial","volume":"375","author":"Raal","year":"2010","journal-title":"Lancet"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198111002095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198111002095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T10:49:49Z","timestamp":1639219789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198111002095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1388198111002095"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2011.10.007","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}